Qiuyun Xu

668 total citations
37 papers, 449 citations indexed

About

Qiuyun Xu is a scholar working on Biomedical Engineering, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Qiuyun Xu has authored 37 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biomedical Engineering, 13 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Qiuyun Xu's work include Photoacoustic and Ultrasonic Imaging (12 papers), Optical Coherence Tomography Applications (9 papers) and Advanced Fluorescence Microscopy Techniques (5 papers). Qiuyun Xu is often cited by papers focused on Photoacoustic and Ultrasonic Imaging (12 papers), Optical Coherence Tomography Applications (9 papers) and Advanced Fluorescence Microscopy Techniques (5 papers). Qiuyun Xu collaborates with scholars based in United States, China and United Kingdom. Qiuyun Xu's co-authors include Rayyan Manwar, Liming Mao, Mohsin Zafar, Xiaorong Zhou, Darius Mehregan, Jie Zhang, Steven Daveluy, Kamran Avanaki, Elmira Jalilian and Saba Adabi and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and International Journal of Molecular Sciences.

In The Last Decade

Qiuyun Xu

33 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiuyun Xu United States 15 193 129 84 66 59 37 449
Kevin Zhang United States 11 168 0.9× 104 0.8× 102 1.2× 71 1.1× 21 0.4× 31 420
Amanda Fisher‐Hubbard United States 6 97 0.5× 93 0.7× 43 0.5× 11 0.2× 31 0.5× 18 458
Sang-Joon Lee South Korea 14 168 0.9× 100 0.8× 52 0.6× 10 0.2× 38 0.6× 55 550
Tjeerd J. Römer Netherlands 11 185 1.0× 98 0.8× 233 2.8× 18 0.3× 47 0.8× 22 719
Jingping Xu China 10 40 0.2× 155 1.2× 46 0.5× 11 0.2× 22 0.4× 20 435
Martin G. Wagner United States 9 246 1.3× 74 0.6× 169 2.0× 3 0.0× 47 0.8× 61 511
Yingzhen Zhang China 13 62 0.3× 162 1.3× 121 1.4× 12 0.2× 25 0.4× 30 753
Stathis Philippou Germany 13 133 0.7× 106 0.8× 75 0.9× 9 0.1× 15 0.3× 24 553
Xiaohui Hao China 13 46 0.2× 173 1.3× 56 0.7× 16 0.2× 41 0.7× 45 590

Countries citing papers authored by Qiuyun Xu

Since Specialization
Citations

This map shows the geographic impact of Qiuyun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuyun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuyun Xu more than expected).

Fields of papers citing papers by Qiuyun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuyun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuyun Xu. The network helps show where Qiuyun Xu may publish in the future.

Co-authorship network of co-authors of Qiuyun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuyun Xu. A scholar is included among the top collaborators of Qiuyun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuyun Xu. Qiuyun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shao, Jing, et al.. (2025). The NLRP3 inflammasome: a therapeutic target of phytochemicals in treating atherosclerosis (a systematic review). Frontiers in Immunology. 16. 1568722–1568722.
3.
Liu, Yongchao, et al.. (2024). Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease. Molecules. 29(2). 379–379. 18 indexed citations
4.
Xu, Qiuyun, Yongsheng Chen, Stephan Miller, et al.. (2024). In Vivo visualization of white matter fiber tracts in the brainstem using low flip angle double echo 3D gradient echo imaging at 3T. NeuroImage. 300. 120857–120857. 1 indexed citations
5.
6.
Wang, Xinhui, Youmin Zhang, Pei Huang, et al.. (2024). PENCIL imaging: A novel approach for neuromelanin sensitive MRI in Parkinson's disease. NeuroImage. 291. 120588–120588. 2 indexed citations
7.
Wang, Yunhan, Qiuyun Xu, Xiaorong Zhou, et al.. (2023). Methyl Canthin-6-one-2-carboxylate Restrains the Migration/Invasion Properties of Fibroblast-like Synoviocytes by Suppressing the Hippo/YAP Signaling Pathway. Pharmaceuticals. 16(10). 1440–1440. 9 indexed citations
8.
Wang, Yunhan, et al.. (2023). High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity. Genes. 14(7). 1406–1406. 6 indexed citations
9.
Wang, Anqi, et al.. (2023). Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators. Molecules. 28(8). 3381–3381. 6 indexed citations
10.
Wang, Yunhan, Boyu Zhang, Jia Ge, et al.. (2023). Predicting Prognosis and Immunotherapy Response in Multiple Cancers Based on the Association of PANoptosis-Related Genes with Tumor Heterogeneity. Genes. 14(11). 1994–1994. 5 indexed citations
11.
Xu, Qiuyun, et al.. (2023). The mechanism of traditional medicine in alleviating ulcerative colitis: regulating intestinal barrier function. Frontiers in Pharmacology. 14. 1228969–1228969. 21 indexed citations
12.
Mao, Liming, Guangxun Meng, Ivan J. Fuss, et al.. (2022). Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function. Frontiers in Immunology. 13. 988862–988862. 24 indexed citations
13.
Xu, Qiuyun, et al.. (2022). Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential. Frontiers in Immunology. 13. 963291–963291. 20 indexed citations
14.
Xu, Qiuyun, Xiaorong Zhou, Warren Strober, & Liming Mao. (2021). Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease. Molecules. 26(6). 1725–1725. 19 indexed citations
15.
Xu, Qiuyun, Jie Zhang, Tingyu Qin, et al.. (2021). The role of the inflammasomes in the pathogenesis of uveitis. Experimental Eye Research. 208. 108618–108618. 17 indexed citations
16.
Zhang, Jie, et al.. (2021). New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease. Journal of Inflammation Research. Volume 14. 4155–4168. 31 indexed citations
17.
Jalilian, Elmira, Qiuyun Xu, Rayyan Manwar, et al.. (2020). Contrast‐enhanced optical coherence tomography for melanoma detection: An in vitro study. Journal of Biophotonics. 13(5). e201960097–e201960097. 16 indexed citations
18.
Xu, Qiuyun, Elmira Jalilian, Rayyan Manwar, et al.. (2019). Monitoring the topical delivery of ultrasmall gold nanoparticles using optical coherence tomography. Skin Research and Technology. 26(2). 263–268. 21 indexed citations
19.
Xu, Qiuyun, et al.. (2018). Swept-Source Optical Coherence Tomography–Supervised Biopsy. Dermatologic Surgery. 44(6). 768–775. 17 indexed citations
20.
Xu, Qiuyun, et al.. (2017). Effect of small and large animal skull bone on photoacoustic signal. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 10064. 100643S–100643S. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026